Ortwein Sara N 4

What Happened Sara N. Ortwein, a director of Sanara MedTech Inc. (SMTI), was granted 4,616 shares of restricted stock on June 4, 2026. The shares are reported as acquired at $0.00 (value at grant $0 in the Form 4). This is an award/compensation grant (an acquisition), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (filed the next day).
• Transaction type/code: A — Award/Grant (restricted stock).
• Shares acquired: 4,616; price reported: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Grant made under the Sanara MedTech 2024 Omnibus Long-Term Incentive Plan. Vesting on the earlier of the 2027 annual shareholder meeting or June 4, 2027, contingent on continued service through that date.
• No 10b5-1 plan, tax-withholding sale, or exercise noted.

Context Restricted stock grants to directors are common as compensation and vest over time; they are not immediate cash purchases or sales. Vesting conditions mean the shares may be forfeited if the director does not remain in service through the vesting date. This type of filing reports compensation/award activity rather than an express market sentiment signal.